Lifestyle medicine is the study and practice of how simple lifestyle measures such as proper diet, proper exercise, and stress reduction are thoughtfully and comprehensively integrated into conventional Western medicine practices. This includes promoting health through prevention and therapeutic strategies. Through the use improved assessment tools, such as coronary computed tomography calcium scoring and exercise capacity, and underused treatment strategies, such as thoughtful diet and exercise interventions coupled with appropriate statin use, practicing clinicians can integrate these lifestyle medicine strategies and significantly decrease the morbidity and mortality of coronary heart disease.
Naghavi M, Falk E, Hecht ES, et al. From vulnerable plaque to vulnerable patient: Part III. A new paradigm for the prevention of heart attack: identification and treatment of the asymptomatic vulnerable patient: executive summary of the Screening for Heart Attack Prevention and Education (SHAPE) task force report. Am J Cardiol. 2006;98(2A):2H-15H.
2.
Rippe JM, Angelopoulos T, Zuckley L. The rationale for intervention to reduce coronary heart disease risk. Am J Lifestyle Med. 2007;1:1-10.
3.
Sibley C, Blumenthal RS, Merz CN, Mosca L. Limitations of current cardiovascular disease risk assessment strategies in women. J Women's Health. 2006;15(1):54-56.
4.
Naghavi M, Libby P, Falk E, et al. From vulnerables plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part II. Circulation. 2003;108:1772-1778.
5.
Greenland P, LaBree L, Azen SP, Doherty TM, Detrano RC. Coronary calcium score combined with Framingham score for risk prediction in asymptomatic individuals. JAMA. 2004;291:210-215.
6.
Kalia NK, Miller LG, Nasir K, Blumenthal RS, Agrawal N, Budoff MJ. Visualizing coronary calcium is associated with improvements in adherence to statin therapy. Atherosclerosis. 2006;185:394-399.
7.
Mackay J, Mensah G. The Atlas of Heart Disease and Stroke. Geneva, Switzerland: World Health Organization and US Centers for Disease Control and Prevention; 2004.
8.
Yarnall KS, Pollack KI, Ostbye T, Krause KM, Michener JL. Primary care: is there enough time for prevention?Am J Pub Health. 2003;93:635-641.
9.
Mozaffarian D, Rimm EB. Fish intake, contaminants, and human health: evaluating the risks and the benefits. JAMA. 2006;296:1885-1899.
10.
Marchioli R, Schweiger C, Tavazzi L, Valagussa F. Efficacy of n-3 polyunsaturated fatty acids after myocardial infarction: results of GISSI-Prevenzione trial. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico. Lipids. 2001;36(suppl):S119-S126.
11.
Mark DB, Lauer MS. Exercise capacity: the prognostic variable that doesn't get enough respect. Circulation. 2003;108:1534-1536.
12.
Gulati M, Pandey DK, Arnsdorf MF, et al. Exercise capacity and the risk of death in women: the St. James Women Take Heart Project. Circulation. 2002;108:1554-1559.
13.
Myers J, Prakash M, Froelicher V, Do D, Partington S, Atwood JE. Exercise capacity and mortality among men referred for exercise testing. N Engl J Med. 2002;346:793-801.
14.
Hayward RA, Hofer TP, Vijan S. Narrative review: lack of evidence for recommended low-density lipoprotein treatment targets: a solvable problem. Ann Intern Med. 2006;145:520-530.
15.
Waters DD. What the statin trials have taught us. Am J Cardiol. 2006;98:129-134.
16.
Hulzebos EH, Helders PJ, Favie NJ, De Bie RA, Brutel de la Riviere A, Van Meeteren NL. Preoperative intensive inspiratory muscle training to prevent postoperative pulmonary complications in high-risk patients undergoing CABG surgery: a randomized clinical trial. JAMA. 2006;296:1851-1857.
